19-Apr-2022 | Zion Market Research
According to Zion Market Research study, General Anxiety Disorder Treatment Market accrued ROI of approximately around US$ 11.01 billion in 2021 and is expected to gain income of almost US$ 14.03 billion in 2028. Apparently, General Anxiety Disorder Treatment Market is anticipated to register highest gains of about 2.8% in time interval of 2022 to 2028. Moreover, expansion of general anxiety disorder treatment market over forecasting timespan is subject to rise in occurrence of psychological problems along with need for effectively managing general anxiety & depression related problems. Furthermore, collaboration between pharmaceutical firms, mental health organizations, and NGOs has facilitated spread of awareness about general anxiety disorder therapy among people, thereby driving market trends. Moreover, rapid spread of COVID-19 pandemic has led to massive rise in general anxiety disorder due to frequent lay-offs by firms due to severe impact on their business as a result of lockdown. This has paved a way for growth of general anxiety disorder treatment market. Furthermore, economic burden of mental ailments on economy & GDP of a country has elevated need for general anxiety disorder therapies, thereby enlarging scope of market expansion.
Antidepressants To Dominate Drug Class Segment In 2022-2028
Growth of antidepressants segment over ensuing years can be credited to its ability in reducing depressive state of mind of an individual. Apart from this, these drugs have proved to be more efficient in comparison to other drugs. Hence, they are prescribed by psychiatrists and neurologists. Additionally, rise in number of candidate drugs in pipeline will boost segmental surge. Moreover, increase in rate of approval of antidepressants by authorities such as the U.S. FDA as mode of treatment for general anxiety disorders will have beneficial impact on segmental growth in near future.
Hospital Pharmacy Segment To Make Notable Contributions Towards General Anxiety Disorder Treatment Market By 2028
Rise in penetration of general anxiety disorder treating drugs in hospital pharmacy sector along with rise in sale of these products by hospital pharmacies will pave a way for segmental expansion. Apart from this, growing patient inclination towards purchase of medicines from nearby hospital pharmacies will steer growth of segment.
Asia Pacific General Anxiety Disorder Treatment Market To Record Highest CAGR Over Forecasting Timeline
Rapid expansion of regional market over forecasting years can be credited to escalating use of antidepressants by doctors for treating individuals with general anxiety disorders. Apart from this, surge in cases of depressive disorders among people will prop up growth of general anxiety disorder treatment industry in Asia Pacific zone.
Some of major participants have strongly influenced growth of general anxiety disorder treatment market and will continue to do so even in foreseeable future. They include GlaxoSmithKline plc, Pfizer, Inc., Johnson & Johnson, Merck & Co. Inc., AstraZeneca, Eli Lilly and Company, Bristol-Myers Squibb, and H. Lundbeck A/S.
Browse the full “General Anxiety Disorder Treatment Market- By Drug Class (Antidepressants, Benzodiazepines, And Buspirone), By Indication (General Anxiety And Depression), And By Distribution Channel (Hospital Pharmacy, Online Pharmacy, And Retail Pharmacy): Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends And Forecast, 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/general-anxiety-disorder-market
The global General Anxiety Disorder Treatment Market is segmented as follows:
By Drug Class
By Distribution Channel
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651